Questcor Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript
Questcor Pharmaceuticals, Inc. (QCOR)
Q2 2012 Earnings Conference Call
July 24, 2012 16:30 ET
Executives
Doug Sherk – EVC GroupDon Bailey – President and Chief Executive OfficerSteve Cartt – Chief Operating OfficerDr. David Young – Chief Scientific OfficerMike Mulroy – Chief Financial OfficerAnalystsDavid Amsellem – Piper JaffraySteve Byrne – Bank of AmericaMario Corso – Caris & CompanyChris Holterhoff – Oppenheimer & CompanyMarko Kozul – Leerink SwannTim Chiang – CRT CapitalBiren Amin – Jefferies & CompanyJim Molloy – ThinkEquityYale Jen – Roth CapitalFrank Pinkerton – SunTrustJuan Sanchez – LadenburgPresentationOperatorPrevious Statements by QCOR
» Questcor Pharmaceuticals' CEO Announces Initial Commercialization Plans for Acthar Rheumatology Indications Conference (Transcript)
» Questcor's CEO Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript)
» Questcor Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript
» Questcor Pharmaceuticals' CEO Presents at Citi 2012 Global Health Care Conference (Transcript)
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV